01113nas a2200397   4500000000100000000000100001000000100002008004100003653002500044653001500069653001000084653003500094653002800129653006500157653003400222653001900256653001100275653001400286653000900300653002600309653005500335100001600390700001400406700001400420700001600434700001400450700001300464700001200477700001300489700002100502245012500523250001500648300001300663490000700676020003200683       2022                            d10aAdministration, Oral10aAdolescent10aAdult10aAnticoagulants/adverse effects10aAspirin/therapeutic use10a*Atrial Fibrillation/complications/drug therapy/epidemiology10a*Brain Ischemia/complications10aCohort Studies10aHumans10aIncidence10aMale10aRetrospective Studies10a*Stroke/epidemiology/etiology/prevention & control1 aA. Ajabnoor1 aS. Zghebi1 aR. Parisi1 aD. Ashcroft1 aM. Rutter1 aT. Doran1 aM. Carr1 aM. Mamas1 aE. Kontopantelis00aIncidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study  a2022/06/08  ae10040030 v19  a1549-1277 (Print)
1549-1277